Gregory Gene Freitag Insider Trading $LECT Axogen, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gregory Gene Freitag.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gregory Gene Freitag. Gregory Gene Freitag is CEO, CFO in AxoGen, Inc. ($LECT) and CFO, General Counsel & SVP BD in AxoGen, Inc. ($LECT) and Director in Axogen, Inc. ($LECT) and General Counsel in AxoGen, Inc. ($LECT) and General Counsel & SVP BD in AxoGen, Inc. ($LECT) and in PDS Biotechnology Corp ($EDGE) and Director in PDS Biotechnology Corp ($EDGE).
Gregory Gene Freitag in Axogen, Inc.
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of Gregory Gene Freitag: Director, CFO, General Counsel & SVP BD, CEO, CFO
Holdings: 252,145 shares
Latest Transaction: Feb 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Gregory Gene Freitag in Axogen, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2021 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Payment of Exercise | F | 18.70 | 545 | 10,192 | 252,352 | 252.9 K to 252.4 K (-0.22 %) |
| Feb 18 2021 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 1,784 | 0 | 252,897 | 251.1 K to 252.9 K (+0.71 %) |
| Feb 18 2021 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Payment of Exercise | F | 18.70 | 1,032 | 19,298 | 251,113 | 252.1 K to 251.1 K (-0.41 %) |
| Feb 18 2021 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 3,377 | 0 | 252,145 | 248.8 K to 252.1 K (+1.36 %) |
| Dec 30 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Sell | S | 17.81 | 916 | 16,314 | 248,345 | 249.3 K to 248.3 K (-0.37 %) |
| Dec 30 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Sell | S | 17.81 | 916 | 16,314 | 248,345 | 249.3 K to 248.3 K (-0.37 %) |
| Dec 30 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 2,300 | 0 | 249,261 | 247 K to 249.3 K (+0.93 %) |
| Dec 30 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 2,300 | 0 | 249,261 | 247 K to 249.3 K (+0.93 %) |
| Dec 22 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Sell | S | 16.42 | 379 | 6,223 | 245,076 | 245.5 K to 245.1 K (-0.15 %) |
| Dec 22 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 925 | 0 | 245,455 | 244.5 K to 245.5 K (+0.38 %) |
| Sep 17 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Option Exercise | M | 3.67 | 4,046 | 14,849 | 22,954 | |
| Sep 17 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Option Exercise | M | 3.67 | 9,000 | 33,030 | 24,000 | |
| Sep 17 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Buy | M | 3.67 | 13,046 | 47,879 | 244,530 | 231.5 K to 244.5 K (+5.64 %) |
| Jun 01 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Option Exercise | M | 3.50 | 125,000 | 437,500 | 0 | |
| Jun 01 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Buy | M | 3.50 | 125,000 | 437,500 | 231,484 | 106.5 K to 231.5 K (+117.39 %) |
| Mar 18 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
| Mar 18 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Option Exercise | A | 8.61 | 24,000 | 206,640 | 24,000 | |
| Feb 20 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Payment of Exercise | F | 14.68 | 529 | 7,766 | 106,484 | 107 K to 106.5 K (-0.49 %) |
| Feb 20 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Grant | A | 0.00 | 1,783 | 0 | 107,013 | 105.2 K to 107 K (+1.69 %) |
| Feb 20 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Payment of Exercise | F | 14.68 | 1,002 | 14,709 | 105,230 | 106.2 K to 105.2 K (-0.94 %) |
| Feb 20 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Grant | A | 0.00 | 3,377 | 0 | 106,232 | 102.9 K to 106.2 K (+3.28 %) |
| Dec 20 2019 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Payment of Exercise | F | 16.73 | 567 | 9,486 | 101,543 | 102.1 K to 101.5 K (-0.56 %) |
| Dec 20 2019 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Grant | A | 0.00 | 1,850 | 0 | 102,110 | 100.3 K to 102.1 K (+1.85 %) |
| Feb 19 2019 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel | Grant | A | 17.57 | 3,377 | 59,334 | 100,260 | 96.9 K to 100.3 K (+3.49 %) |
| Dec 31 2018 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel | Option Exercise | A | 0.00 | 4,600 | 0 | 4,600 | |
| Dec 31 2018 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel | Option Exercise | A | 19.17 | 18,500 | 354,645 | 18,500 | |
| Dec 04 2018 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel | Sell | S | 33.00 | 45,000 | 1,485,000 | 95,865 | 140.9 K to 95.9 K (-31.95 %) |
| Nov 15 2018 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel | Sell | S | 32.25 | 20,000 | 645,000 | 140,865 | 160.9 K to 140.9 K (-12.43 %) |
| Mar 23 2018 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | M | 4.81 | 15,000 | 72,150 | 0 | |
| Mar 23 2018 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | M | 2.46 | 16,000 | 39,360 | 0 | |
| Mar 23 2018 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Payment of Exercise | F | 38.50 | 1,874 | 72,149 | 160,865 | 162.7 K to 160.9 K (-1.15 %) |
| Mar 23 2018 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Buy | M | 4.81 | 15,000 | 72,150 | 162,739 | 147.7 K to 162.7 K (+10.15 %) |
| Mar 23 2018 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Payment of Exercise | F | 38.50 | 1,022 | 39,347 | 147,739 | 148.8 K to 147.7 K (-0.69 %) |
| Mar 23 2018 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Buy | M | 2.46 | 16,000 | 39,360 | 148,761 | 132.8 K to 148.8 K (+12.05 %) |
| Dec 20 2017 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | A | 0.00 | 3,700 | 0 | 3,700 | |
| Dec 20 2017 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | A | 27.00 | 22,100 | 596,700 | 22,100 | |
| Sep 27 2017 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | M | 2.74 | 10,000 | 27,400 | 36,000 | |
| Sep 27 2017 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Payment of Exercise | F | 18.90 | 1,450 | 27,405 | 99,666 | 101.1 K to 99.7 K (-1.43 %) |
| Sep 27 2017 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Buy | M | 2.74 | 10,000 | 27,400 | 101,116 | 91.1 K to 101.1 K (+10.98 %) |
| Aug 29 2017 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | M | 2.74 | 23,000 | 63,020 | 46,000 | |
| Aug 29 2017 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Payment of Exercise | F | 16.65 | 3,785 | 63,020 | 91,116 | 94.9 K to 91.1 K (-3.99 %) |
| Aug 29 2017 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Buy | M | 2.74 | 23,000 | 63,020 | 94,901 | 71.9 K to 94.9 K (+31.99 %) |
| Mar 14 2017 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | M | 2.74 | 23,000 | 63,020 | 69,000 | |
| Mar 14 2017 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Buy | M | 2.74 | 23,000 | 63,020 | 71,901 | 48.9 K to 71.9 K (+47.03 %) |
| Jan 03 2017 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | A | 8.95 | 50,000 | 447,500 | 50,000 | |
| May 31 2016 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | A | 5.45 | 15,000 | 81,750 | 15,000 | |
| May 31 2016 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel & S ... | Option Exercise | A | 5.45 | 6,000 | 32,700 | 6,000 | |
| Dec 30 2015 | LECT | AxoGen, Inc. | Freitag Gregory Gene | CFO, General Counse ... | Option Exercise | A | 3.38 | 83,000 | 280,540 | 83,000 | |
| Dec 30 2015 | LECT | AxoGen, Inc. | Freitag Gregory Gene | CFO, General Counse ... | Option Exercise | A | 5.09 | 9,000 | 45,810 | 9,000 | |
| Jun 01 2010 | LECT | AxoGen, Inc. | Freitag Gregory Gene | CEO, CFO | Option Exercise | A | 3.50 | 125,000 | 437,500 | 125,000 |
Page: 1